Omburtamab
Omburtamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Omburtamab is under investigation in clinical trial NCT03275402 (131i-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/leptomeningeal Metastases).
| Trade Name | Omburtamab |
| Generic | Omburtamab |
| Omburtamab Other Names | Omburtamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Omburtamab
